In cancer, it has been shown that the increased RNA expression of MYEOV can be caused by genomic rearrangements or duplications of 11q13 (Janssen et al., 2002b; Liang et al., 2020) or by hypomethylation of MYEOV’s promoter (Fang et al., 2019; Liang et al., 2020). This evidence concerns the gene MYEOV and cancer.